STOCK TITAN

111 Financials

YI
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows 111 (YI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI YI FY2024

Cost discipline and working-capital release turned a thin-margin, inventory-heavy model from cash burn to self-funding in FY2024.

The move to operating break-even came without a richer gross margin: gross margin held near 5.8% after 5.7%, so the core economics did not suddenly become much richer. The bigger shift was overhead compression and working-capital release, with selling/admin expense cut to $9.7M from $31.6M as inventory and receivables both shrank.

Cash conversion improved faster than earnings: the company generated $36.0M of operating cash flow and $34.0M of free cash flow even though reported net income was still slightly negative. That pattern usually points to cash being freed from day-to-day working capital, not just a cleaner income statement.

The balance sheet remains creditor-funded, with liabilities exceeding assets by about $88.0M and a current ratio of 1.1x, so the liquidity cushion is still fairly thin. The year ended with $63.3M of cash after a financing outflow, which suggests operations briefly carried more of the load even though equity stayed negative.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 14 / 100
Financial Profile 14/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of 111's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
21

111 has an operating margin of -0.0%, meaning the company retains $-0 of operating profit per $100 of revenue. This below-average margin results in a low score of 21/100, suggesting thin profitability after operating expenses. This is up from 0.0% the prior year.

Growth
21

111's revenue declined 9% year-over-year, from $2.0B to $1.8B. This contraction results in a growth score of 21/100.

Leverage
0

111 has elevated debt relative to equity (D/E of -4.13), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity
17

111's current ratio of 1.09 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
26

111's free cash flow margin of 0.9% results in a low score of 26/100. Capital expenditures of $636K absorb a large share of operating cash flow.

Piotroski F-Score Weak
3/9

111 passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed
-5.29x

For every $1 of reported earnings, 111 generates $-5.29 in operating cash flow ($17.0M OCF vs -$3.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk
-0.1x

111 earns $-0.1 in operating income for every $1 of interest expense (-$340K vs $5.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.8B
YoY-9.0%
5Y CAGR+7.4%

111 generated $1.8B in revenue in fiscal year 2025. This represents a decrease of 9.0% from the prior year.

EBITDA
$1.4M
YoY-48.2%

111's EBITDA was $1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 48.2% from the prior year.

Net Income
-$3.2M
YoY-13.1%

111 reported -$3.2M in net income in fiscal year 2025. This represents a decrease of 13.1% from the prior year.

EPS (Diluted)
$-0.05
YoY+0.0%

111 earned $-0.05 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$16.4M
YoY-51.7%

111 generated $16.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 51.7% from the prior year.

Cash & Debt
$73.1M
YoY+15.4%
5Y CAGR-16.7%

111 held $73.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
176M

111 had 176M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
5.8%
YoY+0.0pp

111's gross margin was 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.0 percentage points from the prior year.

Operating Margin
-0.0%
YoY-0.0pp
5Y CAGR+5.8pp

111's operating margin was -0.0% in fiscal year 2025, reflecting core business profitability. This is down 0.0 percentage points from the prior year.

Net Margin
-0.2%
YoY-0.0pp
5Y CAGR+5.5pp

111's net profit margin was -0.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.0 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$636K
YoY-69.5%
5Y CAGR-30.5%

111 invested $636K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 69.5% from the prior year.

YI Income Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

YI Balance Sheet

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Total Assets $314.6M-17.6% $381.9M-12.2% $435.1M-13.6% $503.7M+2.0% $493.6M+6.4% $463.8M+100.5% $231.3M+2.8% $224.9M
Current Assets $303.9M-16.3% $363.0M-12.1% $413.1M-11.9% $469.2M+6.7% $439.7M-0.1% $440.3M+106.9% $212.8M-2.9% $219.2M
Cash & Equivalents $73.1M+15.4% $63.3M-25.5% $85.0M-13.0% $97.7M-5.9% $103.8M-43.1% $182.3M+118.4% $83.5M-32.8% $124.2M
Inventory $142.8M-24.9% $190.1M-4.9% $199.9M-8.0% $217.3M+23.5% $175.9M+49.8% $117.5M+68.2% $69.8M+127.8% $30.7M
Accounts Receivable $37.1M-34.4% $56.6M-25.1% $75.6M+6.7% $70.9M+11.7% $63.5M+153.9% $25.0M+166.7% $9.4M+125.6% $4.2M
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $415.0M-11.7% $470.0M-9.1% $517.3M-8.2% $563.8M+8.2% $520.8M+27.3% $409.1M+240.5% $120.1M+156.0% $46.9M
Current Liabilities $279.4M-12.9% $320.9M-17.0% $386.6M-2.1% $395.1M+18.2% $334.2M+33.8% $249.8M+124.8% $111.1M+142.9% $45.7M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$100.4M-14.1% -$88.0M-7.1% -$82.2M-36.7% -$60.1M-121.0% -$27.2M-149.7% $54.8M-50.9% $111.6M-37.3% $178.1M
Retained Earnings -$564.9M-6.2% -$532.1M+1.1% -$537.9M-8.3% -$496.8M-5.2% -$472.3M-31.7% -$358.6M-32.6% -$270.5M-34.4% -$201.3M

YI Cash Flow Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

YI Financial Ratios

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 1.09-0.0 1.13+0.1 1.07-0.1 1.19-0.1 1.32-0.4 1.76-0.2 1.92-2.9 4.79
Debt-to-Equity -4.13+1.2 -5.34+1.0 -6.29+3.1 -9.38+9.8 -19.15-26.6 7.47+6.4 1.08+0.8 0.26
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$100.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

111 (YI) reported $1.8B in total revenue for fiscal year 2025. This represents a -9.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

111 (YI) revenue declined by 9% year-over-year, from $2.0B to $1.8B in fiscal year 2025.

No, 111 (YI) reported a net income of -$3.2M in fiscal year 2025, with a net profit margin of -0.2%.

111 (YI) reported diluted earnings per share of $-0.05 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

111 (YI) had EBITDA of $1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

111 (YI) had a gross margin of 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

111 (YI) had an operating margin of -0.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

111 (YI) had a net profit margin of -0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

111 (YI) generated $16.4M in free cash flow during fiscal year 2025. This represents a -51.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

111 (YI) generated $17.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

111 (YI) had $314.6M in total assets as of fiscal year 2025, including both current and long-term assets.

111 (YI) invested $636K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

111 (YI) had 176M shares outstanding as of fiscal year 2025.

111 (YI) had a current ratio of 1.09 as of fiscal year 2025, which is considered adequate.

111 (YI) had a debt-to-equity ratio of -4.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

111 (YI) had a return on assets of -1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

111 (YI) has negative shareholder equity of -$100.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

111 (YI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

111 (YI) has an earnings quality ratio of -5.29x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

111 (YI) has an interest coverage ratio of -0.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

111 (YI) scores 14 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top